doi:10.3969/j.issn.1671-2587.2021.02.029

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2021, Vol. 23 ›› Issue (2): 268-272.DOI: 10.3969/j.issn.1671-2587.2021.02.029

Received:2020-07-05 Online:2021-04-20 Published:2021-04-19

[1] LOZANO M,CID J,MÜLLER T H.Plasma treated with methylene blue and light: clinical efficacy and safety profile[J].Transfus Med Rev,2013,27(4):235-240.
[2] NOENS L,VILARIÑO M D,MEGALOU A,et al.International,prospective haemovigilance study on methylene blue-treated plasma[J].Vox Sang,2017,112(4):352-359.
[3] 国家卫生健康委.血站技术操作规程(2019版)[EB/OL].(2019-04-28). http://www.nhc.gov.cn/yzygj/s7658/201905/bdd4f4ccd15c4201bfb6d9e7492d7fab.shtml.
[4] 中华人民共和国国家质量监督检验检疫总局,中国国家标准化管理委员会.全血及成分血质量要求:GB 18469—2012[S].北京:中国标准出版社,2012.
[5] TCHEN S,SULLIVAN J B.Clinical utility of midodrine and methylene blue as catecholamine-sparing agents in intensive care unit patients with shock[J].J Crit Care,2020,57:148-156.
[6] CICCHETTI A,BERRINO A,CASINI M,et al.Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use[J].Blood Transfus,2016,14(4):287-386.
[7] EICKMANN M,GRAVEMANN U,HANDKE W,et al.Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus,Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light[J].Vox Sang,2020,115(3):146-151.
[8] FADDY H M,FRYK J J,HALL R A,et al.Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light[J].Transfusion,2019,59(7):2223-2227.
[9] EICKMANN M,GRAVEMANN U,HANDKE W,et al.Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light,respectively[J].Transfusion,2018,58(9):2202-2207.
[10] FRYK J J,MARKS D C,HOBSON-PETERS J,et al.Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light[J].Transfusion,2017,57(11):2677-2682.
[11] FRYK J J,MARKS D C,HOBSON-PETERS J,et al.Deng
ue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light[J].Transfusion,2016,56(9):2278-2285.
[12] RAMSEY G.Hemostatic efficacy of pathogen-inactivated blood components[J].Semin Thromb Hemost,2016,42(2): 172-182.
[13] YANG C H,BIAN G H,YANG H,et al.Quantitative evaluation of plasma after methylene blue and white light treatment in four Chinese blood centers[J].Transfus Apher Sci,2013,49(3):631-639.
[14] GRAVEMANN U,HANDKE W,SUMIAN C,et al.Plasma temperature during methylene blue/light treatment influences virus inactivation capacity and product quality[J].Vox Sang,2018,113(4):368-377.
[15] 钟锐,刘嘉馨,曹晔,等.亚甲蓝光化学法对血浆凝血因子活性的影响研究[J].中国输血杂志,2011,24(1):40-42.
[16] NUBRET K,DELHOUME M,ORSEL I,et al.Anaphylactic shock to fresh-frozen plasma inactivated with methylene blue[J].Transfusion,2011,51(1):125-128.
[17] BOST V,ODENT-MALAURE H,CHAVARIN P,et al.A regional haemovigilance retrospective study of four types of therapeutic plasma in a ten-year survey period in France[J].Vox Sang,2013,104(4):337-341.
[18] POLITIS C,KAVALLIEROU L,HANTZIARA S,et al.Haemovigilance data on the use of methylene blue virally inactivated fresh frozen plasma with the Theraflex MB-Plasma System in comparison to quarantine plasma: 11 years' experience[J].Transfus Med,2014,24(5):316-320.
[19] MUÑIZ-DIAZ E,PUIG L.Allergic and anaphylactic reactions to methylene-blue-treated plasma in Catalonia in the period 2008-2013[J].Trasfusione Del Sangue,2014,12(4):628-630.
[20] DEWACHTER P,CASTRO S,NICAISE-ROLAND P,et al.Anaphylactic reaction after methylene blue-treated plasma transfusion[J].Br J Anaesth,2011,106(5):687-689.
[21] AKAZAWA M,WU Y H,LIU W M.Allergy-like reactions to methylene blue following laparoscopic chromopertubation: a systematic review of the literature[J].Eur J Obstet Gynecol Reprod Biol,2019,238:58-62.
[22] 杜斌,陈俊良,唐筛娣,等.亚甲蓝对百草枯中毒大鼠胸腺T淋巴细胞亚群与氧化应激的影响[J].中国病理生理杂志,2016,32(7):1307-1311.
[23] WANG J Q,ZHAO C Y,KONG P,et al.Methylene blue alleviates experimental autoimmune encephalomyelitis by modulating AMPK/SIRT1 signaling pathway and Th17/Treg immune response[J].J Neuroimmunol,2016,299:45-52.
[24] WERNER I,GUO F W,BOGERT N V,et al.Methylene blue modulates transendothelial migration of peripheral blood cells[J].PLoS One,2013,8(12): e82214. DOI:10.1371/journal.pone.0082214.
[25] 姚仁南,陈玲,刘军权,等.病毒灭活血浆对人CIK细胞功能影响的体外实验研究[J].中国输血杂志,2012,25(8): 741-744.
[26] JIANG C L,YANG W Y,WANG C Y,et al.Methylene blue-mediated photodynamic therapy induces macrophage apoptosis via ROS and reduces bone resorption in periodontitis[J].Oxid Med Cell Longev,2019,2019:1529520.
[27] TREVISAN E,MENEGAZZI R,ZABUCCHI G,et al.Effect of methylene blue photodynamic therapy on human neutrophil functional responses[J].J Photochem Photobiol B,2019,199:111605.
[28] JACQUOT C,DELANEY M.Pathogen-inactivated blood products for pediatric patients: blood safety,patient safety,or both?[J].Transfusion,2018,58(9): 2095-2101.
[29] GILLMAN P K.CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity[J].J Psychopharmacol,2011,25(3):429-436.
[30] SCOTTON W J,HILL L J,WILLIAMS A C,et al.Serotonin syndrome: pathophysiology,clinical features,management,and potential future directions[J].Int J Tryptophan Res,2019,12:1178646919873925.
[31] ZUSCHLAG Z D,WARREN M W,K SCHULTZ S.Serotonin toxicity and urinary analgesics: a case report and systematic literature review of methylene blue-induced serotonin syndrome[J].Psychosomatics,2018,59(6):539-546.
[32] AUERBACH S S,BRISTOL D W,PECKHAM J C,et al.Toxicity and carcinogenicity studies of methylene blue trihydrate in F344N rats and B6C3F1 mice[J].Food Chem Toxicol,2010,48(1):169-177.
[33] ARUNACHALAM SUBRAMANIAN N,KRISHNAMOO
RTHY V,KRISHNAN V,et al.An unexplained oxidative haemolysis with pigment nephropathy[J].BMJ Case Rep,2019,12(7):e230994.
[34] VANHINSBERGH L,UTHAYA S,BAIN B J.Methylene blue-induced Heinz body hemolytic Anemia in a premature neonate[J].Am J Hematol,2018,93(5):716-717.
[35] ALLEGAERT K,MISEREZ M,LERUT T,et al.Methemoglobinemia and hemolysis after enteral administration of methylene blue in a preterm infant: relevance for pediatric surgeons[J].J Pediatr Surg,2004,39(1):E35-E37.
[36] JENA S K,NAIK S S.Methemoglobinaemia after diagnostic hystero-laparoscopic chromopertubation in a sub-fertile patient[J].J Obstet Gynaecol,2019,39(7): 1025-1026.
[37] TCHEN S,SULLIVAN J B.Clinical utility of midodrine and methylene blue as catecholamine-sparing agents in intensive care unit patients with shock[J].J Crit Care,2020,57:148-156.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	JIA Yan-jun, ZHAO Xu-ying, WEI Zhen-zhen. Effects of Resveratrol on Platelet Oxidative Stress and Aging Index and Storage Time [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 137-141.
[2]	WANG Lei, WU Xue-zhong. Retrospective Analysis of Rh (D,C, c, E, e) Antigens Compatibility between Blood Recipients and Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 181-185.
[3]	GAN Shan, DUAN Ling, HU Hong-bing. The Clinical Use of Blood in Exchange Transfusion for Severe Neonatal Hyperbilirubinemia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 185-188.
[4]	DUAN Bing-zheng, WANG Shu-lian, LIAN Jun-hui, et al. Clinical Significance of Direct Anti-human Globulin Test in Patients' Blood Transfusion Effect [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 189-191.
[5]	YANG Chun-chen, RONG Rui-ming, LI Yang, et al. An Evaluation Model of Clinical Blood Transfusion Records Based on Cov-AHP-fuzzy Comprehensive Evaluation Method [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 192-196.
[6]	GUO Wei-jie, LIU Ze-ya, ZHANG Fan, et al. Meta-analysis：Unexpected Antibody Positive Rate of Blood Donors in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 202-212.
[7]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 236-239.
[8]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 239-241.
[9]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 248-255.
[10]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 259-262.
[11]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(1): 13-17.
[12]	HAO Yi-wen. Evaluating Indications for Red Blood Cell Transfusion and Therapeutic Efficacy:An Overall and Dynamic View [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 590-593.
[13]	HUANG Rong, CHEN Ting-ting, ZHU Long-fei, et al. Blood Transfusion in Maternal Neonatal Diseases [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 610-612.
[14]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 613-616.
[15]	ZHOU Yao, LUO Hai-yan, SONG Hui-min, et al. Effect of Perioperative Blood Protection Measures on Rapid Rehabilitation of Elderly Patients with Total Hip Arthroplasty [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 617-620.